|
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) |
|
Aurinia Pharmaceuticals Inc
AUPH's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Aurinia Pharmaceuticals Inc growth rates, revenue grew
by 24.32 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 596
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Aurinia Pharmaceuticals Inc realized net income compared to net loss a year ago in III. Quarter 2024
• More on AUPH's Growth
|
|
Aurinia Pharmaceuticals Inc realized a net loss in trailing twelve months.
Aurinia Pharmaceuticals Inc realized cash reduction of $ -0.06 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 5.29.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
• More on AUPH's Valuation
|
|
|
|
|
Aurinia Pharmaceuticals Inc realized net loss in trailing twelve months.
Aurinia Pharmaceuticals Inc realized cash outflow of $ -0.06per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 5.29.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
Aurinia Pharmaceuticals Inc Price to Book Ratio is at 3.01 lower than Industry Avg. of 89.07. and higher than S&P 500 Avg. of 0.01
• More on AUPH's Valuation
|
|
AUPH's Profitability Comparisons
|
Aurinia Pharmaceuticals Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 17.33 %.
Aurinia Pharmaceuticals Inc net profit margin of 21.17 % is currently ranking no. 28 in Major Pharmaceutical Preparations industry, ranking no. 51 in Healthcare sector and number 672 in S&P 500.
Profitability by Segment |
Total |
21.17 % |
|
|
Aurinia Pharmaceuticals Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 17.33 %.
Aurinia Pharmaceuticals Inc net profit margin of 21.17 % is currently ranking no. 28 in Major Pharmaceutical Preparations industry, ranking no. 51 in Healthcare sector and number 672 in S&P 500.
• More on AUPH's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com